Hypersensitivity to the active substance, loratadine or to any of the excipients.
Precautions:
Pregnancy and lactation:
It is not recommended during pregnancy (no data on the safety of use). Desloratadine was found in the body of newborns / breast-fed children by women who took the medicine. The effect of desloratadine on the newborn / infant organism is unknown. A decision should be made whether to discontinue breast-feeding or discontinue the treatment taking into account the benefits of breastfeeding for the child and the benefits of treatment for the mother.
Side effects:
Common: headache, insomnia (in children under 2 years of age), dry mouth, diarrhea (in children under 2 years of age), fatigue, fever (in children under 2 years of age). Very rare: hallucinations, dizziness, drowsiness, insomnia, psychomotor agitation, convulsions, tachycardia, palpitations, abdominal pain, nausea, vomiting, indigestion, diarrhea, increased liver enzymes, increased bilirubin, hepatitis, muscle pain, hypersensitivity reactions (such as: anaphylactic reaction, angioneurotic edema, dyspnoea, pruritus, rash and urticaria). Not known: photosensitivity.
Dosage:
Orally. Adults and adolescents ≥12 years: 5 mg (10 ml) once a day; children 6-11 years: 2.5 mg (5 ml) once a day; children 1-5 years: 1.25 mg (2.5 ml) once a day. The safety and efficacy of desloratadine 0.5 mg / ml as an oral solution in children in the 1st year have not been established (data are not available). There is insufficient data on the efficacy of desloratadine in children from 1 year to 11 years of age and adolescents aged 12 to 17 years. In periodic allergic rhinitis (symptoms occur less than 4 days in a week or less than 4 weeks), treatment should be discontinued after the symptoms have resolved and resumed when they recur. In chronic allergic rhinitis (symptoms occur for 4 days in a week or more and for more than 4 weeks) you can continue treatment during the period of exposure to the allergen.Way of giving. The drug can be taken regardless of meals.